Scientific Advisors

Steve Gillies, PhD

Chief Scientfic Officer, Alopexx Oncology

Dr. Gillies is an expert in the creation and development of recombinant antibodies and immunotherapies. Currently he serves as both the CSO of Alopexx Oncology and as the Founder and CEO of Provenance Biopharmaceuticals corp. Prior to founding Provenance, Dr. Gillies led all scientific and business endeavors of Lexigen Pharmaceuticals Corp. After Lexigen’s acquisition in… Read More »

Barry Greenberg, PhD

Director, Neuroscience Drug Discovery and Development, University Health Network Director of Strategy, Toronto Dementia Research Alliance Toronto Western Research Institute

Barry Greenberg has been involved in Alzheimer’s disease research and drug discovery since 1985. He has held a series of positions internationally in the US, Sweden and Canada within the biotechnology and pharmaceutical industries. Dr. Greenberg was the leader of a drug discovery project at AstraZeneca through lead optimization, involving up to 50 individuals from… Read More »

Gerald B. Pier, Ph.D

Prof. of Medicine, Harvard Medical School, Microbiologist, Brigham and Women's Hospital

Dr. Gerald Pier is a Professor of Medicine (Microbiology and Immunobiology) at Harvard Medical School and a Microbiologist at Brigham and Women’s Hospital where he has been conducting independent research since 1978. He received his Ph.D. in microbiology from the University of California at Berkeley. A National Research Council post-doctoral fellowship at the Walter Reed… Read More »